cysteine sulfinic acid has been researched along with Epilepsy in 2 studies
cysteine sulfinic acid: metabolite of sulfur-containing amino acids
Epilepsy: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rico, MJ | 1 |
| Merlin, LR | 2 |
| Cuellar, JC | 1 |
| Griffith, EL | 1 |
2 other studies available for cysteine sulfinic acid and Epilepsy
| Article | Year |
|---|---|
Evidence that phospholipase D activation prevents group I mGluR-induced persistent prolongation of epileptiform bursts.
Topics: Animals; Cyclopropanes; Cysteine; Epilepsy; GABA Antagonists; GABA-A Receptor Antagonists; Glycine; | 2004 |
Contrasting roles of protein kinase C in induction versus suppression of group I mGluR-mediated epileptogenesis in vitro.
Topics: Action Potentials; Biological Clocks; Cells, Cultured; Cysteine; Epilepsy; Hippocampus; Neuronal Pla | 2005 |